Publication-Hepatitis C Virus Drug Resistance-associated Substitutions: State of the Art Summary
Forum staff and scientific experts on behalf of the Drug Resistance Working Group of the Forum for Collaborative HIV Research's HCV Drug Development Advisory Group (HCV DrAG) provide a comprehensive, systematic review of all resistance information available from sponsors' trials as a tool to inform the HCV drug development field. The report is now available as early view with DOI citation. Click here to read the report.
On July 30, 2015, The White House Office of AIDS Policy convened in Atlanta, GA to unveil the National HIV/AIDS Strategy, updated to 2020 after President Obama signed an executive order to mark the official release. Major changes to the NHAS include an expanded prevention toolkit, the role of The Affordable Care Act, new recommendations for HIV testing and treatment, improving the HIV Care Continuum, and using innovative research to discover new methods and tools. Click here to read the Updated National HIV/AIDS Strategy.
Missing from The 2015 International AIDS Society Conference earlier this week, was Bob Munk, a long time friend, colleague, and AIDS activist who passed away earlier this month. His valuable and lifelong contribution to the AIDS effort in the US will never be forgotten.
Click here to view a tribute to Bob Munk.
Innovation Countdown 2030 Inaugural Report, Reimagining Global Health
Today, PATH launched the the Innovation Countdown 2030 (IC2030) inaugural report, Reimagining Global Health, which features 30 lifesaving innovations and thought pieces by 11 prominent thinkers. The report was officially announced at the Financing for Development conference in Addis Ababa, Ethiopia at a special side-event co-hosted by Every Women, Every Child, the Bill & Melinda Gates Foundation, the Government of Norway, PATH, UN Foundation, and Grand Challenges Canada. The report is now available for download at www.IC2030.org.
Treatment Action Group's 2014 Research in Action Awards, Sunday, December 14, 2014
TAG's annual Research in Action Awards (RIAA) event honors activists, scientists, philanthropists, and creative artists who have made extraordinary contributions to the fight against AIDS. Resources raised at RIAA provide vital support for TAG’s programs throughout the year, and enable us to honor champions in the fight to end AIDS
Read more »
EC Member Dr. Kenneth Mayer discusses PrEP in The Huffington Post
Dr. Kenneth Mayer, Harvard Medical School Professor and Medical Director of The Fenway Institute discusses the use of PrEP in The Huffington Post. Click here to read the full article.
Dr. Judith Aberg receives Dr. George Baehr Endowed Professorship of Clinical Medicine
Dr. Judith Aberg, who was recruited to the Icahn School of Medicine at Mount Sinai in January 2014 to serve as Chief of the Division of Infectious Diseases and Immunology and Director of the Infectious Diseases Clinical and Translational Research Center received the Dr. George Baehr Endowed Professorship of Clinical Medicine Sept 29, 2014.
A Community Town Hall on HIV Cure Research, Washington DC
A Community Town Hall on HIV Cure Research, Washington DC, October 14th, 2014 6:30-8:30pmThis is a free event, please RSVP online at Eventbrite: http://bit.ly/1ro3RFF
Read more »
Clinical Infectious Diseases Honors Dr. John Bartlett
Clinical Infectious Diseases is honoring the Forum's Executive Committee Co-chair Dr. John Bartlett with a special supplement issue titled, "The John Bartlett Festschrift: Celebrating a Career in Medicine." Click here to read the articles in the supplement issue.
PRESS RELEASE: First Public Meeting of Cross-Sector HIV Cure Project Convenes June 17th in Washington, DC
On June 13-14, at a time when dozens of research trials are challenging the long-held assumption that HIV is incurable, the Forum for Collaborative HIV Research is convening the first public meeting of the Forum HIV Cure Project: Focus on Regulatory Issues, a multi-stakeholder project that involves expert working groups and engagement with the broader HIV community to address emerging scientific and regulatory hurdles in HIV cure research. Click here to read the full press release.
|
|
.png)
